Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitors

Background:  Mast cells (MC) are multifunctional effector cells of the immune system. They derive from uncommitted CD34+ hemopoietic progenitor cells (HPC). Depending on the stage of maturation and the environment, MC variably express differentiation‐ and activation‐linked antigens. Little is known, however, about the regulation of expression of such antigens in immature human MC.

[1]  H. Hoffmann,et al.  Human mast cells express receptors for IL‐3, IL‐5 and GM‐CSF; a partial map of receptors on human mast cells cultured in vitro , 2004, Allergy.

[2]  A. Órfão,et al.  Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis , 2003, British journal of haematology.

[3]  Michael R. Müller,et al.  Activation of Human Mast Cells through Stem Cell Factor Receptor (KIT) Is Associated with Expression of bcl-2 , 2002, International Archives of Allergy and Immunology.

[4]  P. Valent,et al.  Signal Transduction—Associated and Cell Activation—Linked Antigens Expressed in Human Mast Cells , 2002, International journal of hematology.

[5]  Michael R. Müller,et al.  Detection of Novel CD Antigens on the Surface of Human Mast Cells and Basophils , 2002, International Archives of Allergy and Immunology.

[6]  O. Majdic,et al.  Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. , 2001, Blood.

[7]  A. Órfão,et al.  Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. , 2001, Leukemia research.

[8]  A. Órfão,et al.  Variable expression of activation‐linked surface antigens on human mast cells in health and disease , 2001, Immunological reviews.

[9]  A. Rogers,et al.  Systemic Mastocytosis , 2000, Digestive Diseases.

[10]  B. Foster,et al.  Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). , 1999, Blood.

[11]  H. Ochi,et al.  T Helper Cell Type 2 Cytokine–Mediated Comitogenic Responses and Ccr3 Expression during Differentiation of Human Mast Cells in Vitro , 1999, The Journal of experimental medicine.

[12]  M. Ebisawa,et al.  Characterization of mast cell-committed progenitors present in human umbilical cord blood. , 1999, Blood.

[13]  P. Valent,et al.  Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. , 1998, The Journal of investigative dermatology.

[14]  A. Órfão,et al.  Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. , 1998, Blood.

[15]  J. Kochan,et al.  Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. , 1997, Journal of immunology.

[16]  K. Matsumoto,et al.  Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. , 1996, Journal of immunology.

[17]  K. Kishi,et al.  Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes , 1996, Immunology.

[18]  M. Oppermann,et al.  Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. , 1995, Journal of immunology.

[19]  L. Ashman,et al.  Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51/CD61 (alpha v beta 3) integrin , 1995 .

[20]  O. Majdic,et al.  Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. , 1993, Journal of immunology.

[21]  K. Zsebo,et al.  Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Zsebo,et al.  Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. , 1992, Blood.

[23]  A. Kagey‐Sobotka,et al.  Immunophenotyping and functional analysis of purified human uterine mast cells. , 1992, Blood.

[24]  D. Metcalfe,et al.  Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. , 1991, Journal of immunology.

[25]  O. Majdic,et al.  Failure to detect IL-3-binding sites on human mast cells. , 1990, Journal of immunology.

[26]  Austen Kf,et al.  Mediators of immediate hypersensitivity reactions. , 1987 .

[27]  C. Figdor,et al.  Development of human connective tissue mast cells from purified blood monocytes. , 1984, Immunology.

[28]  J. Peters,et al.  Spleen colony-forming cell as common precursor of tissue mast cells and granulocytes , 1981, Nature.

[29]  M. Kaliner,et al.  The mast cell. , 1981, Critical reviews in immunology.

[30]  T. Zuberbier,et al.  Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. , 2000, The Journal of investigative dermatology.

[31]  T. Nakahata,et al.  Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. , 1998, Blood.

[32]  P. Valent,et al.  The growth and differentiation of mast cells. , 1991, Progress in growth factor research.

[33]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[34]  A. Carmagnola.  [The mast cell]. , 1988, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[35]  K. Austen,et al.  Mediators of immediate hypersensitivity reactions. , 1987, The New England journal of medicine.

[36]  K. Ishizaka,et al.  Activation of mast cells for mediator release through IgE receptors. , 1984, Progress in allergy.